NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,436,000 | +34.2% | 20,000 | -20.0% | 0.50% | +8.8% |
| Q1 2021 | $3,305,000 | -6.8% | 25,000 | +22.0% | 0.46% | -18.2% |
| Q4 2020 | $3,547,000 | -10.9% | 20,500 | -42.7% | 0.56% | -27.6% |
| Q3 2020 | $3,979,000 | +57.4% | 35,750 | -52.6% | 0.77% | +171.8% |
| Q4 2018 | $2,528,000 | -66.0% | 75,500 | -46.7% | 0.28% | -48.0% |
| Q3 2018 | $7,428,000 | +3.2% | 141,750 | -38.4% | 0.55% | +2.8% |
| Q2 2018 | $7,199,000 | +15.7% | 230,000 | -19.4% | 0.53% | +8.1% |
| Q1 2018 | $6,224,000 | +12.7% | 285,500 | +4.4% | 0.49% | +21.2% |
| Q4 2017 | $5,525,000 | +32.2% | 273,500 | +29.9% | 0.40% | +43.6% |
| Q3 2017 | $4,178,000 | – | 210,500 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |